Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery. [electronic resource]
Producer: 20200413Description: 52-62 p. digitalISSN:- 1538-7836
- Adult
- Aged
- Blood Loss, Surgical -- prevention & control
- Coagulants -- administration & dosage
- Elective Surgical Procedures -- adverse effects
- Female
- Hemostasis -- drug effects
- Humans
- Male
- Middle Aged
- Prospective Studies
- Recombinant Proteins -- administration & dosage
- Severity of Illness Index
- Time Factors
- Treatment Outcome
- Young Adult
- von Willebrand Diseases -- blood
- von Willebrand Factor -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.